Elzasonan-D8 is a labelled analogue of Elzasonan (E517000). Elzasonan is a selective 5-hydroxytryptamine 1B receptor antagonist that was developed by Pfizer (and then later discontinued in 2008) to treat patients with major depressive disorder and obsessive compulsive disorder.
您的位置：
